Pancrelipaze-R (Pancrexan)
Product detail for Pancrelipaze-R, INN: pancrelipaze-r. Therapeutic area: Metabolic. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-018
INN
pancrelipaze-r
Therapeutic Area
Metabolic
Status
Pending
Owner
Lieselotte van der Berg
Created
2022-03-15
Last Updated
2023-12-23
Markets
3
Presentations
| Form | Strength | Route |
|---|---|---|
| Powder for injection | 25 mg | Intravitreal |
| Film-coated tablet | 10 mg | Transdermal |
| Concentrate for solution for infusion | 400 mg | Inhalation |
| Oral solution | 400 mg | Topical |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-015 | Haemoferrin | haemoferrin | 64023-69-5 | biologic | Active |
| SUB-030 | Mavacamtamex | mavacamtamex | 81169-60-9 | small-molecule | Pending |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| SAHPRA-2022-0018 | India | Lifecycle Extension | Submitted | Marcus Webb | 2023-11-18 |
| MHRA-2022-0048 | India | Type IB Variation | In Progress | Carlos Mendez | 2022-07-29 |
| SAHPRA-2022-0078 | India | sMAA | Active | Priya Sharma | 2023-06-26 |
Markets (3)